Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0B4G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,624
Award facts
- Contract value 100% obligated
- $32,623.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $32,623.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL units). This non-competitive delivery order, which is scheduled for completion by February 5, 2026, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare programs worldwide.
AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. Dupixent, a specialty immunosuppressant biologic medication, represents the type of specialized pharmaceutical product that AmerisourceBergen routinely delivers through its DLA contract portfolio. The company's extensive federal contracting history demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical commodities supporting military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F0B4G?
SPE2DR26F0B4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F0B4G worth?
The government has obligated $32,624 on SPE2DR26F0B4G.
Is contract SPE2DR26F0B4G an order under another contract?
Yes. SPE2DR26F0B4G is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B4G competed?
The extent of competition for SPE2DR26F0B4G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award